They died in front of me. I feel bad sometimes speaking about this.
A decade after Ebola swept through West Africa and claimed nearly 4,000 lives in Sierra Leone alone, the country has begun vaccinating 20,000 frontline health workers with Ervebo — a protection that did not exist when it was needed most. The campaign, launched in Freetown on December 5, 2024, through a partnership of global health institutions, marks the first nationwide preventive Ebola vaccination effort in the nation most devastated by the 2014 outbreak. It is a moment of hard-won progress shadowed by the knowledge that science arrived too late for those who shaped the urgency behind it.
- A vaccine that could have saved thousands now reaches the hands of health workers who remember burying colleagues lost to the same disease they were trying to treat.
- The 2014 Ebola epidemic hollowed out Sierra Leone's healthcare system, killing 7% of its medical workforce and leaving survivors like Hassan Kamara — who lost nine family members — to carry wounds that a decade has not erased.
- The government, backed by Gavi, WHO, and UNICEF, is racing to close the gap between vulnerability and protection, targeting 20,000 frontline workers before the next outbreak can find the same openings the last one did.
- Health workers are expressing relief, but officials are not declaring victory — Ebola remains endemic in the region, and the September 2024 emergence of Marburg virus in Rwanda signals that the cycle of viral threat is far from broken.
On December 5, 2024, health workers in Freetown lined up for a single dose of Ervebo — a moment that would have been unimaginable ten years earlier, when Ebola was spreading unchecked through West Africa and no vaccine existed anywhere in the world.
Sierra Leone is now home to the first nationwide Ebola vaccination campaign in the country the 2014 outbreak hit hardest. Working alongside Gavi, the WHO, and UNICEF, the government aims to reach 20,000 frontline workers. Health Minister Dr. Austin Demby called it plainly what it is: an investment in the safety of Sierra Leone's people.
The shadow of 2014 still falls over everything. That epidemic — the deadliest on record — began in Guinea and spread across borders, infecting up to 28,000 people and killing more than 11,000 worldwide. Sierra Leone lost nearly 4,000 lives and 7 percent of its entire healthcare workforce. Hassan Kamara, a Freetown resident, survived an outbreak that killed nine of his relatives. Of eleven people in his household, only he and his infant daughter remained. 'They died in front of me,' he said. 'I feel bad sometimes speaking about this because of what I went through.'
The health workers receiving the vaccine this week carry their own memories. Community health worker Collins Thomas watched colleagues die while caring for patients during the outbreak. 'It was scary, because we knew nothing about the disease,' he recalled. 'With this vaccine, we know we are protected.' Gavi's chief executive, Dr. Sania Nishtar, called the campaign a historic milestone — made more meaningful, she noted, precisely because it is happening in the country that suffered most.
The relief is real, but so is the vigilance. Officials warn that Ebola remains endemic in the regions where it originated. In September 2024, Rwanda reported cases of Marburg virus — similarly contagious, potentially fatal in up to 88 percent of cases, and believed, like Ebola, to originate in fruit bats. The pattern is familiar: a virus emerges, spreads, kills, and leaves behind a population that must learn to live with the knowledge it could happen again. Sierra Leone's campaign is both a victory and a reckoning — proof that protection is possible, and a quiet memorial to all those lost before it arrived.
On December 5, 2024, health workers in Freetown lined up to receive a single dose of Ervebo, the Ebola vaccine. It was a moment that would have seemed impossible a decade earlier, when the virus was spreading unchecked through West Africa and no protective vaccine existed anywhere in the world.
Sierra Leone is now launching the first nationwide Ebola vaccination campaign in the country most devastated by the 2014 outbreak. The government, working with Gavi, the World Health Organization, and UNICEF, aims to vaccinate 20,000 frontline workers across the nation. Health Minister Dr. Austin Demby framed the effort plainly: "This is an investment in the safety of our people and a healthier Sierra Leone."
The scale of what happened ten years ago still defines the moment. The 2014 Ebola epidemic was the deadliest on record. It began in Guinea and crossed borders into Sierra Leone and Liberia, ultimately infecting up to 28,000 people across the region. More than 11,000 died worldwide. Sierra Leone bore the heaviest weight: nearly 4,000 deaths in a single country. The healthcare system was hollowed out—7 percent of the nation's medical workforce was lost to the disease, many of them killed while treating patients they could not save.
Hassan Kamara, a Freetown resident, lost nine relatives during that outbreak. Of the eleven people in his household, only he and his infant daughter survived. "They died in front of me," he told the Associated Press. "I feel bad sometimes speaking about this because of what I went through." His words carry the weight of a man who watched his family disappear and lived through it.
The healthcare workers greeting the vaccine campaign this week carry their own scars. Collins Thomas, a community health worker in Freetown, remembers colleagues who died caring for patients during the city's outbreak. "It was scary, because we knew nothing about the disease and learned along the line," he recalled. "With this vaccine, we know we are protected." There is relief in that statement—the relief of someone who has already paid the price and now sees a way to prevent others from doing the same.
Dr. Sania Nishtar, chief executive of Gavi, called the campaign a historic milestone. "To have the first nationwide preventive vaccination campaign take place in the country most deeply impacted by the 2014 outbreak makes this historic milestone even more meaningful," she said. The irony is sharp: the vaccine exists now, but it comes a decade too late for the thousands who died waiting for it.
Yet the threat has not disappeared. Officials warn that Ebola remains endemic in regions where it originated, and the virus could emerge again. The emergence of similar threats underscores the vulnerability. In September, Rwanda reported cases of Marburg virus, a disease as contagious as Ebola and potentially fatal in up to 88 percent of cases. Like Ebola, Marburg is believed to originate in fruit bats and spreads through contact with bodily fluids or contaminated surfaces. The pattern repeats: a virus emerges, spreads, kills, and leaves behind a population learning to live with the knowledge that it could happen again.
Sierra Leone's vaccination campaign represents both a victory and a reckoning—proof that science can provide protection, but also a reminder of what was lost while waiting for that protection to arrive.
Citas Notables
They died in front of me. I feel bad sometimes speaking about this because of what I went through.— Hassan Kamara, Ebola survivor
It was scary, because we knew nothing about the disease and learned along the line. With this vaccine, we know we are protected.— Collins Thomas, community health worker in Freetown
La Conversación del Hearth Otra perspectiva de la historia
Why does this campaign matter now, a full decade later? Couldn't they have done this sooner?
The vaccine didn't exist during the 2014 outbreak. Ervebo was developed after the epidemic ended. So this isn't about delay—it's about finally having the tool they didn't have before. But yes, the timing is bittersweet. The people who died can't be protected.
What does it mean for someone like Hassan Kamara, who lost nine family members, to see this vaccine arrive?
It's complicated. The vaccine can't bring anyone back. But it means his infant daughter—one of only two survivors in his household—has protection now. It means the next outbreak, if it comes, won't necessarily look like the last one.
Are health workers actually willing to take it, given what they witnessed?
The opposite. Collins Thomas and others who lost colleagues are embracing it. They know the cost of being unprotected. They've seen it firsthand. That's not hesitation—that's urgency.
Is Ebola actually still a threat, or is this more about closure?
It's both. Officials say the virus remains endemic in certain regions. Guinea went three years without a case, but that doesn't mean it's gone. And now there's Marburg in Rwanda, which is even more lethal. The threat is real, which is why the vaccine matters.
What does this say about global health preparedness?
That we're still reactive, not proactive. We develop vaccines after outbreaks, not before. Sierra Leone is vaccinating 20,000 frontline workers now—but 11,000 people died before we had the tool to prevent it. That's the hard lesson embedded in this campaign.